FOR IMMEDIATE RELEASE

Santa Barbara, CA — June 5, 2025 — Santa Barbara Nutrients, Inc., a public benefit corporation dedicated to advancing kidney and metabolic health through science-backed nutritional solutions, is pleased to announce the appointment of Stu Caplan, CFP®, to its Advisory Board.

Mr. Caplan is a Senior Wealth Strategist at Members’ Wealth, a boutique wealth management firm specializing in integrated investment strategy, tax-aware financial planning, and multigenerational wealth counsel for high-net-worth individuals, families, and business owners. With over two decades of experience in portfolio management, estate strategies, and tax planning, he has held leadership roles in multi-family offices and registered investment advisors, including serving as Principal and Chief Investment Officer at a prominent advisory firm focused on ultra-high-net-worth families.

Beyond his professional accomplishments, Mr. Caplan brings a deeply personal connection to Santa Barbara Nutrients' mission. He lives with polycystic kidney disease (PKD) and draws inspiration from his mother, a kidney transplant recipient whose resilience fuels his advocacy. His firsthand experience with PKD underscores his commitment to advancing research and ensuring families affected by the disease have access to better education, resources, and hope.

“Stu’s unique blend of financial expertise and personal experience with PKD offers invaluable insights as we continue to develop innovative solutions for kidney health,” said Dr. Thomas Weimbs, President of Santa Barbara Nutrients. “His dedication to advocacy and strategic thinking will greatly enhance our efforts to support the PKD community.”

Mr. Caplan holds an MBA from the Robert H. Smith School of Business at the University of Maryland and a BSBA in Marketing and Entrepreneurship, cum laude with honors, from the Eller College of Management at the University of Arizona.

Santa Barbara Nutrients is committed to transforming kidney health through research-based nutrition products and educational resources. The company's flagship product, KetoCitra®, is a medical food designed for the dietary management of individuals with chronic kidney disease, including PKD. The addition of Mr. Caplan to the Advisory Board reinforces the company's dedication to integrating patient perspectives into its mission.

About Santa Barbara Nutrients, Inc.

Santa Barbara Nutrients is a public benefit corporation headquartered in Santa Barbara, California. Founded in 2019, the company emerged from research at the University of California, Santa Barbara, particularly from studies conducted by Dr. Thomas Weimbs and his team on the benefits of ketogenic dietary interventions for managing PKD. The experienced Santa Barbara Nutrients team comprises kidney researchers and industry experts dedicated to bringing novel medical foods and other innovative products to market, aiming to help individuals with kidney disease and other metabolic health conditions. 

For more information, please visit www.SantaBarbaraNutrients.com or contact info@sbnutrients.com.

Media Contact:

Santa Barbara Nutrients, Inc.
Email: info@sbnutrients.com
Phone: +1 805-272-0029

Note: This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.